FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2997471043> ?p ?o ?g. }

• W2997471043 endingPage "1151" @default.
• W2997471043 startingPage "1143" @default.
• W2997471043 abstract "The ALSYMPCA study established a 3.6 month Overall Survival (OS) benefit in metastatic Castration Resistant Prostate Cancer (mCRPC) patients treated with Radium‐223 dichloride (Ra‐223) over placebo. Here we report clinical outcomes of Ra‐223 treatment in a nonstudy population. In this prospective registry, patients from 20 Dutch hospitals were included prior to Ra‐223 treatment. Clinical parameters collected included previous treatments and Adverse Events. Primary outcome was 6 months Symptomatic Skeletal Event (SSE)‐free survival, while secondary outcomes included Progression‐Free Survival (PFS) and Overall Survival (OS). Of the 305 patients included, 300 were evaluable. The mean age was 73.6 years, 90% had ≥6 bone metastases and 74.1% were pretreated with Docetaxel, 19.5% with Cabazitaxel and 80.5% with Abiraterone and/or Enzalutamide. Of all patients, 96.7% were treated with Ra‐223 and received a median of 5 cycles. After a median follow‐up of 13.2 months, 6 months SSE‐free survival rate was 83%, median PFS was 5.1 months and median OS was 15.2 months. Six months SSE‐free survival rate and OS were comparable with those reported in ALSYMPCA. “Previous Cabazitaxel treatment” and “bone‐only metastases” were independent predictors of a shorter and longer PFS, respectively, while above‐median LDH and “bone‐only metastases” were independent predictors of shorter and longer OS, respectively. Toxicity was similar as reported in the ALSYMPCA trial. These results suggest that in a nonstudy population, Ra‐223 treatment is well‐tolerated, equally effective as in the ALSYMPCA population and that patients not previously treated with Cabazitaxel benefit most from Ra‐223." @default.
• W2997471043 created "2020-01-10" @default.
• W2997471043 creator A5004731469 @default.
• W2997471043 creator A5017136846 @default.
• W2997471043 creator A5020320519 @default.
• W2997471043 creator A5025180096 @default.
• W2997471043 creator A5029485498 @default.
• W2997471043 creator A5031117246 @default.
• W2997471043 creator A5034599698 @default.
• W2997471043 creator A5037160835 @default.
• W2997471043 creator A5047950538 @default.
• W2997471043 creator A5050429823 @default.
• W2997471043 creator A5056550523 @default.
• W2997471043 creator A5059758441 @default.
• W2997471043 creator A5073141213 @default.
• W2997471043 creator A5076342427 @default.
• W2997471043 creator A5077644578 @default.
• W2997471043 creator A5083080568 @default.
• W2997471043 date "2020-01-21" @default.
• W2997471043 modified "2023-10-07" @default.
• W2997471043 title "A prospective observational registry evaluating clinical outcomes of Radium‐223 treatment in a nonstudy population" @default.
• W2997471043 cites W1757407923 @default.
• W2997471043 cites W1971463425 @default.
• W2997471043 cites W2018856880 @default.
• W2997471043 cites W2019289198 @default.
• W2997471043 cites W2019607817 @default.
• W2997471043 cites W2055346449 @default.
• W2997471043 cites W2065574422 @default.
• W2997471043 cites W2102969047 @default.
• W2997471043 cites W2108679313 @default.
• W2997471043 cites W2110534364 @default.
• W2997471043 cites W2113701976 @default.
• W2997471043 cites W2123526148 @default.
• W2997471043 cites W2141454098 @default.
• W2997471043 cites W2148643283 @default.
• W2997471043 cites W2166918329 @default.
• W2997471043 cites W2170731023 @default.
• W2997471043 cites W2278392405 @default.
• W2997471043 cites W2565838866 @default.
• W2997471043 cites W2588172683 @default.
• W2997471043 cites W2607894842 @default.
• W2997471043 cites W2735160137 @default.
• W2997471043 cites W2790714932 @default.
• W2997471043 cites W2799375096 @default.
• W2997471043 cites W2911490798 @default.
• W2997471043 cites W2951546295 @default.
• W2997471043 doi "https://doi.org/10.1002/ijc.32851" @default.
• W2997471043 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7383569" @default.
• W2997471043 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31875956" @default.
• W2997471043 hasPublicationYear "2020" @default.
• W2997471043 type Work @default.
• W2997471043 sameAs 2997471043 @default.
• W2997471043 citedByCount "13" @default.
• W2997471043 countsByYear W29974710432020 @default.
• W2997471043 countsByYear W29974710432021 @default.
• W2997471043 countsByYear W29974710432022 @default.
• W2997471043 countsByYear W29974710432023 @default.
• W2997471043 crossrefType "journal-article" @default.
• W2997471043 hasAuthorship W2997471043A5004731469 @default.
• W2997471043 hasAuthorship W2997471043A5017136846 @default.
• W2997471043 hasAuthorship W2997471043A5020320519 @default.
• W2997471043 hasAuthorship W2997471043A5025180096 @default.
• W2997471043 hasAuthorship W2997471043A5029485498 @default.
• W2997471043 hasAuthorship W2997471043A5031117246 @default.
• W2997471043 hasAuthorship W2997471043A5034599698 @default.
• W2997471043 hasAuthorship W2997471043A5037160835 @default.
• W2997471043 hasAuthorship W2997471043A5047950538 @default.
• W2997471043 hasAuthorship W2997471043A5050429823 @default.
• W2997471043 hasAuthorship W2997471043A5056550523 @default.
• W2997471043 hasAuthorship W2997471043A5059758441 @default.
• W2997471043 hasAuthorship W2997471043A5073141213 @default.
• W2997471043 hasAuthorship W2997471043A5076342427 @default.
• W2997471043 hasAuthorship W2997471043A5077644578 @default.
• W2997471043 hasAuthorship W2997471043A5083080568 @default.
• W2997471043 hasBestOaLocation W29974710431 @default.
• W2997471043 hasConcept C121608353 @default.
• W2997471043 hasConcept C126322002 @default.
• W2997471043 hasConcept C141071460 @default.
• W2997471043 hasConcept C197934379 @default.
• W2997471043 hasConcept C2776551883 @default.
• W2997471043 hasConcept C2776694085 @default.
• W2997471043 hasConcept C2777899217 @default.
• W2997471043 hasConcept C2778971682 @default.
• W2997471043 hasConcept C2780192828 @default.
• W2997471043 hasConcept C2780739268 @default.
• W2997471043 hasConcept C2781190966 @default.
• W2997471043 hasConcept C2908647359 @default.
• W2997471043 hasConcept C535046627 @default.
• W2997471043 hasConcept C61367390 @default.
• W2997471043 hasConcept C71924100 @default.
• W2997471043 hasConcept C99454951 @default.
• W2997471043 hasConceptScore W2997471043C121608353 @default.
• W2997471043 hasConceptScore W2997471043C126322002 @default.
• W2997471043 hasConceptScore W2997471043C141071460 @default.
• W2997471043 hasConceptScore W2997471043C197934379 @default.
• W2997471043 hasConceptScore W2997471043C2776551883 @default.
• W2997471043 hasConceptScore W2997471043C2776694085 @default.
• W2997471043 hasConceptScore W2997471043C2777899217 @default.

• next